Kyle Gano
Chief Executive Officer at Neurocrine Biosciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Neurocrine Biosciences Inc., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Neurocrine Biosciences Inc. May 21, 202598.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 1, 2026 | Neurocrine Biosciences Inc. | Option exercise | +614 | — | — |
| Nov 1, 2026 | Neurocrine Biosciences Inc. | Shares withheld for tax | −332 | $146.10 | $48,505 |
| Sep 11, 2026 | Neurocrine Biosciences Inc. | Grant or award | +6,275 | — | — |
| Sep 11, 2026 | Neurocrine Biosciences Inc. | Shares withheld for tax | −3,386 | $156.22 | $528,961 |
| Sep 11, 2026 | Neurocrine Biosciences Inc. | Grant or award | +1,842 | — | — |
| Sep 11, 2026 | Neurocrine Biosciences Inc. | Shares withheld for tax | −994 | $156.22 | $155,283 |
| Feb 13, 2026 | Neurocrine Biosciences Inc. | Option exercise | +2,241 | — | — |
| Feb 13, 2026 | Neurocrine Biosciences Inc. | Shares withheld for tax | −1,210 | $124.12 | $150,185 |
| Feb 13, 2026 | Neurocrine Biosciences Inc. | Option exercise | +2,566 | — | — |
| Feb 13, 2026 | Neurocrine Biosciences Inc. | Shares withheld for tax | −1,385 | $124.12 | $171,906 |
| Feb 13, 2026 | Neurocrine Biosciences Inc. | Grant or award | +9,968 | — | — |
| Feb 13, 2026 | Neurocrine Biosciences Inc. | Shares withheld for tax | −5,378 | $124.12 | $667,517 |
| Feb 12, 2026 | Neurocrine Biosciences Inc. | Option exercise | +4,907 | — | — |
| Feb 12, 2026 | Neurocrine Biosciences Inc. | Shares withheld for tax | −2,648 | $123.10 | $325,969 |
| Jan 31, 2026 | Neurocrine Biosciences Inc. | Option exercise | +2,927 | — | — |
Questions about Kyle Gano
What boards is Kyle Gano on?
Kyle Gano sits on the board of Neurocrine Biosciences Inc.
What company is Kyle Gano the CEO of?
Kyle Gano is Chief Executive Officer of Neurocrine Biosciences Inc.
How long has Kyle Gano served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.